Lifecore Biomedical, Inc. LFCR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s total liabilities & equity?
- Lifecore Biomedical, Inc. (LFCR) reported total liabilities & equity of $225.5M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s total liabilities & equity changed year-over-year?
- Lifecore Biomedical, Inc.'s total liabilities & equity decreased by 5.8% year-over-year, from $239.34M to $225.5M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s total liabilities & equity?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s total liabilities & equity has grown at a -14.8% compound annual growth rate (CAGR), from $501.89M to $225.5M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.